Epidemiology Outcomes
Sharon Y. Irving, PhD,
University of Pennsylvania
Disclosure(s): Alcresta Therapeutics: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 1, 2025); ASPEN: Board Member/Officer/Trustee (Ongoing); BeVera Solutions: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024)